The Rosetta study is comparing two therapies for urge urinary incontinence. The two therapies are Botox®, a medication injected into the bladder versus InterStim® Therapy, a reversible treatment that uses mild electrical pulses to stimulate nerves going to your bladder (neuromodulation) that influence bladder function.

• Participation will last up to 2 years.
• Eligible participants are women who report symptoms of urge incontinence or overactive bladder (OAB), are 21 years of age or older, experience this leakage two or more times per day, and have tried other treatments for OAB, including oral medication.
• Urodynamics, a routine bladder evaluation, will be required prior to study enrollment.
• Routine clinical tests and a 3-day bladder diary (a daily record of your voids and episodes of urinary leakage) will be completed to confirm final eligibility.
• If you are eligible you will receive up to $500 for completed visits, calls, questionnaires, and diaries
• For more information on the Rosetta study please call Mary Raynor at 919-401-1016

For more information, contact Mary Raynor at 919-401-1016.